Francesca Barone

2023

In 2023, Francesca Barone earned a total compensation of $706.9K as Chief Scientific Officer at Candel Therapeutics, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$80,560
Option Awards$89,577
Salary$413,005
Stock Awards$110,534
Other$13,200
Total$706,876

Barone received $413K in salary, accounting for 58% of the total pay in 2023.

Barone also received $80.6K in non-equity incentive plan, $89.6K in option awards, $110.5K in stock awards and $13.2K in other compensation.

Rankings

In 2023, Francesca Barone's compensation ranked 1,588th out of 2,918 executives tracked by ExecPay. In other words, Barone earned more than 45.6% of executives.

ClassificationRankingPercentile
All
1,588
out of 2,918
46th
Division
Manufacturing
935
out of 1,608
42nd
Major group
Chemicals And Allied Products
599
out of 901
34th
Industry group
Drugs
583
out of 864
33rd
Industry
Biological Products, Except Diagnostic Substances
159
out of 211
25th
Source: SEC filing on May 30, 2024.

Barone's colleagues

We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2023.

2023

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2023

Jason Amello

Candel Therapeutics

Chief Financial Officer

News

You may also like